{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:16:07Z","timestamp":1791094567852,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.vaccine.2017.09.055","type":"journal-article","created":{"date-parts":[[2017,9,23]],"date-time":"2017-09-23T21:45:18Z","timestamp":1506203118000},"page":"6129-6136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Investigating the candidacy of a capsular polysaccharide-based glycoconjugate as a vaccine to combat Haemophilus influenzae type a disease: A solution for an unmet public health need"],"prefix":"10.1016","volume":"35","author":[{"given":"Andrew D.","family":"Cox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantelle","family":"Cairns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"St. Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny","family":"Vinogradov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Arbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.09.055_b0005","doi-asserted-by":"crossref","first-page":"365","DOI":"10.14745\/ccdr.v40i17a04","article-title":"Collaboration on a public-health driven vaccine initiative","volume":"40","author":"Desai","year":"2014","journal-title":"Can Commun Dis Report"},{"key":"10.1016\/j.vaccine.2017.09.055_b0010","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S1473-3099(08)70264-0","article-title":"Changing epidemiology of invasive Haemophilus influenzae disease","volume":"8","author":"Tsang","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.055_b0015","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1021\/ja00374a033","volume":"104","author":"Egan","year":"1982","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.vaccine.2017.09.055_b0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0882-4010(89)90058-2","article-title":"The molecular basis of pathogenicity in Haemophilus influenzae: comparative virulence of genetically related capsular transformants and correlation with changes of the capsulation locus cap","volume":"7","author":"Zwahlen","year":"1989","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2017.09.055_b0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1128\/IAI.35.1.95-104.1982","article-title":"Differential complement resistance mediates virulence of Haemophilus influenzae type b","volume":"35","author":"Sutton","year":"1982","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.09.055_b0030","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S1473-3099(13)70170-1","article-title":"Haemophilus influenzae serotype a as a cause of serious invasive infections","volume":"14","author":"Ulanova","year":"2014","journal-title":"Lancet Inf Dis"},{"key":"10.1016\/j.vaccine.2017.09.055_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3402\/ijch.v72i0.21142","article-title":"The epidemiology of invasive disease due to Haemophilus influenzae serotype a in the Canadian North from 2000 to 2010","volume":"72","author":"Rotondo","year":"2013","journal-title":"Int J Circumpolar Health"},{"key":"10.1016\/j.vaccine.2017.09.055_b0040","doi-asserted-by":"crossref","first-page":"932","DOI":"10.3201\/eid1906.121805","article-title":"Haemophilus influenzae serotype a invasive disease, Alaska, USA, 1983\u20132011","volume":"19","author":"Bruce","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.055_b0045","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1016\/j.vaccine.2017.06.001","article-title":"The changing epidemiology of invasive Haemophilus influenzae disease: Emergence and global presence of serotype a strains that may require a new vaccine for control","volume":"35","author":"Tsang","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.09.055_b0050","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1128\/IAI.01774-06","article-title":"Haemophilus influenzae type a infection and its prevention","volume":"75","author":"Jin","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.09.055_b0055","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1021\/bi961989y","article-title":"Structure of the variable and conserved lipopolysaccharide oligosaccharide epitopes expressed by Haemophilus influenzae serotype b strain Eagan","volume":"36","author":"Masoud","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.vaccine.2017.09.055_b0060","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4049\/jimmunol.37.2.103","article-title":"A simplified formula for diphtheric toxin broth","volume":"37","author":"Mueller","year":"1939","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.09.055_b0065","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0021-9673(01)95457-3","article-title":"Rapid purification of diphtheria toxin by phenyl-sepharose and DEAE-cellulose chromatography","volume":"269","author":"Rappuoli","year":"1983","journal-title":"J Chromatogr"},{"key":"10.1016\/j.vaccine.2017.09.055_b0070","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1128\/IAI.61.7.3026-3031.1993","article-title":"Protein D of Haemophilus influenzae is not a universal Immunoglobulin D-binding protein","volume":"61","author":"Sasaki","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.09.055_b0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0008-6215(00)90283-0","article-title":"Ultrasonic irradiation of bacterial polysaccharides. Characterization of the depolymerized products and some applications of the process","volume":"152","author":"Szu","year":"1986","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.vaccine.2017.09.055_b0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.biologicals.2004.11.002","article-title":"Alignment of absolute and relative molecular size specifications for a polyvalent pneumococcal polysaccharide vaccine (PNEUMOVAX 23)","volume":"33","author":"MacNair","year":"2005","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2017.09.055_b0085","doi-asserted-by":"crossref","unstructured":"St. Michael F, Cairns CM, Filion AL, Giuliani MM, Biolchi A, Brunelli B, Richards JC, Cox AD. Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: conjugates based on core oligosaccharides. Glycoconj J 2014;31:25\u201339.","DOI":"10.1007\/s10719-013-9500-z"},{"key":"10.1016\/j.vaccine.2017.09.055_b0090","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1021\/ac60231a048","article-title":"Quantitative determination of monosaccharides as their alditol acetates by gas liquid chromatography","volume":"37","author":"Sawardeker","year":"1965","journal-title":"Anal Chem"},{"key":"10.1016\/j.vaccine.2017.09.055_b0095","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0008-6215(02)00161-1","article-title":"R, Moxon ER, Richards JC. Structural analysis of the lipopolysaccharide from Neisseria meningitidis strain BZ157 galE: localisation of two phosphoethanolamine residues in the inner core oligosaccharide","volume":"337","author":"Cox","year":"2002","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.vaccine.2017.09.055_b0100","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10719-013-9489-3","article-title":"St. Michael F, Aubry A, Cairns C, Strong P, Hayes A, Logan SM. Investigating the candidacy of a lipoteichoic acid-based glycoconjugate as a vaccine to combat Clostridium difficile","volume":"30","author":"Cox","year":"2013","journal-title":"Glycoconj J"},{"key":"10.1016\/j.vaccine.2017.09.055_b0105","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1016\/j.vaccine.2005.06.011","article-title":"Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: developmental chemistry and investigation of immunological responses following immunization of mice and rabbits","volume":"23","author":"Cox","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.09.055_b0110","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1016\/j.vaccine.2015.07.034","article-title":"PHiD-CV induces anti-Protein D antibodies but does not augment pulmonary clearance of non-typeable Haemophilus influenzae in mice","volume":"33","author":"Siggins","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.09.055_b0115","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/00006454-199306000-00006","article-title":"Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants","volume":"12","author":"Bulkow","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.09.055_b0120","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1016\/j.vaccine.2016.06.038","article-title":"The impact of administration of conjugate vaccines containing cross reacting material on Haemophilus influenzae type b antibody responses in infants: A systematic review and meta-analysis of randomized controlled trials","volume":"34","author":"Voysey","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.09.055_b0125","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.4161\/hv.26109","article-title":"Protein carriers of conjugate vaccines: characteristics, development and clinical trials","volume":"9","author":"Pichichero","year":"2013","journal-title":"Hum Vaccin Immunother"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17313038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17313038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T08:55:22Z","timestamp":1693040122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17313038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":25,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0264410X17313038"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.055","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating the candidacy of a capsular polysaccharide-based glycoconjugate as a vaccine to combat Haemophilus influenzae type a disease: A solution for an unmet public health need","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2017 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}